“In transition: ensuring the sexual and reproductive health and rights of transgender populations.” A roundtable discussion

This roundtable discussion is the result of a research symposium entitled In Transition: Gender [Identity], Law & Global Health where participants took up the challenge to engage with the question: What will it take to ensure the sexual and reproductive health and rights (SRHR) of transgender populations across the globe? The barriers to overcome are fierce, and include not only lack of access to health services and insurance but also stigma and discrimination, harassment, violence, and violations of rights at every turn. Transgender people must of course lead any sort of initiatives to improve their lives, even as partnerships are needed to build capacity, translate lived experience into usable data, and to make strategic decisions. The SRHR of transgender people can only be addressed with attention to the social, cultural, legal, historical, and political contexts in which people are situated, with social, psychological, medical, and legal gender affirmation as a key priority shaping any intervention. Bringing together nine diverse yet complementary perspectives, our intent is to jumpstart a global and multigenerational conversation among transgender activists, lawyers, policy-makers, programmers, epidemiologists, economists, social workers, clinicians and all other stakeholders to help think through priority areas of focus that will support the needs, rights, and health of transgender populations. Making the changes envisioned here is possible but it will require not only the advocacy, policy, programmatic and research directions presented here but also struggle and action locally, nationally, and globally

Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines

Lack of estrogen receptor (ER) and presence of vimentin (VIM) associate with poor prognosis in human breast cancer. We have explored the relationships between ER, VIM, and invasiveness in human breast cancer cell lines. In the matrigel outgrowth assay, ER+/VIM- (MCF-7, T47D, ZR-75-1), and ER-/VIM- (MDA-MB-468, SK-Br-3) cell lines were uninvasive, while ER-/VIM+ (BT549, MDA-MB-231, MDA-MB-435, MDA-MB-436, Hs578T) lines formed invasive, penetrating colonies. Similarly, ER-/VIM+ cell lines were significantly more invasive than either the ER+/VIM- or ER-/VIM- cell lines in the Boyden chamber chemoinvasion assay. Invasive activity in nude mice was only seen with ER-/ VIM+ cell lines MDA-MB-231, MDA-MB-435 and MDA-MB-436. Hs578T cells (ER-/VIM+) showed hematogenous dissemination to the lungs in one of five mice, but lacked local invasion. The ER-/VIM+ MCF-7ADR subline was significantly more active than the MCF-7 cells in vitro, but resembled the wild-type MCF-7 parent in in vivo activity. Data from these cell lines suggest that human breast cancer progression results first in the loss of ER, and subsequently in VIM acquisition, the latter being associated with increased metastatic potential through enhanced invasiveness. The MCF-7ADR data provide evidence that this transition can occur in human breast cancer cells. Vimentin expression may provide useful insights into mechanisms of invasion and/or breast cancer cell progression

Faith, science and the political imagination : moderate Republicans and the politics of embryonic stem cell research

The rise of the Christian Right and the pro-life movement over the last fifty years has transformed US politics in general, and the Republican Party in particular. Its seemingly all-pervasive influence on contemporary US politics has commanded much social scientific attention. However, policy debates over embryonic stem cell research during the Presidency of George W. Bush exposed deep, moral fissures amongst American conservatives. As one of the most recent ‘hot button’ issues in America's culture wars, embryonic stem cell research appeared to energize the under-studied moderate wing of the ‘Grand Old Party’ (GOP), which belatedly emerged to challenge what often seems like a homogeneous and monolithic Christian Right. This paper argues that during the 109th United States Congress, moderate Republicans identified in embryonic stem cells a powerful entity around which to mobilise themselves as a set of otherwise diverse interests. This enabled them to imagine a political future for themselves in which they could successfully challenge the hegemony of the Christian Right in grassroots Republican Party politics. In states like Missouri, however, which fought a referendum on embryonic stem cell research in the 2006 midterm elections, it could be argued that emboldened GOP moderates overplayed their hand. Furthermore, a fully-formed GOP moderate counter-movement to the Christian Right failed to materialize as centrists and moderates were amongst the first to lose their seats when the Democrats reclaimed Congress at the 2006 midterms